{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:48:59Z","timestamp":1760147339364,"version":"build-2065373602"},"reference-count":105,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T00:00:00Z","timestamp":1674518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"ALiCE","award":["LA\/P\/0045\/2020","UIDB\/00511\/2020","UIDP\/00511\/2020","POCI-01-0145-FEDER-028715"],"award-info":[{"award-number":["LA\/P\/0045\/2020","UIDB\/00511\/2020","UIDP\/00511\/2020","POCI-01-0145-FEDER-028715"]}]},{"name":"LEPABE","award":["LA\/P\/0045\/2020","UIDB\/00511\/2020","UIDP\/00511\/2020","POCI-01-0145-FEDER-028715"],"award-info":[{"award-number":["LA\/P\/0045\/2020","UIDB\/00511\/2020","UIDP\/00511\/2020","POCI-01-0145-FEDER-028715"]}]},{"name":"national funds through FCT\/MCTES (PIDDAC)","award":["LA\/P\/0045\/2020","UIDB\/00511\/2020","UIDP\/00511\/2020","POCI-01-0145-FEDER-028715"],"award-info":[{"award-number":["LA\/P\/0045\/2020","UIDB\/00511\/2020","UIDP\/00511\/2020","POCI-01-0145-FEDER-028715"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Acute promyelocytic leukemia (APL) is phenotypically characterized by the accumulation of dysplastic promyelocytes, resulting from a cytogenetic condition due to the balanced chromosomal translocation t(15;17)(q22;q21). Current first-line treatment of APL includes all-trans retinoic acid (all-trans RA), with or without arsenic trioxide, combined with chemotherapy, and a chemotherapy-free approach wherein arsenic trioxide is used alone or in combination with all-trans RA. The usage of all-trans RA revolutionized the treatment of APL, with survival rates of 80 to 90% being achieved. The mechanism of action of all-trans RA is based on regulation of gene transcription, promoting the differentiation of leukemic promyelocytes. Encapsulation technology has been explored as an innovative strategy to overcome the major drawbacks related to the all-trans RA oral administration in the APL treatment. The most recently published works on this subject highlight the development and optimization of carrier-based delivery systems based in microparticle formulations obtained by spray-drying to be used in the treatment of APL. The ultimate goal is to obtain a controlled delivery system for RA oral administration capable of providing a slow release of this bioactive compound in the intestinal lumen.<\/jats:p>","DOI":"10.3390\/ph16020180","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T03:23:49Z","timestamp":1674617029000},"page":"180","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pharmaceutical\/Clinical Strategies in the Treatment of Acute Promyelocytic Leukemia: All-Trans Retinoic Acid Encapsulation by Spray-Drying Technology as an Innovative Approach\u2013Comprehensive Overview"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2846-0354","authenticated-orcid":false,"given":"Ant\u00f3nia","family":"Gon\u00e7alves","sequence":"first","affiliation":[{"name":"LEPABE\u2014Laboratory for Process Engineering, Environment, Biotechnology and Energy, Department of Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"},{"name":"ALiCE\u2014Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2778-8374","authenticated-orcid":false,"given":"Fernando","family":"Rocha","sequence":"additional","affiliation":[{"name":"LEPABE\u2014Laboratory for Process Engineering, Environment, Biotechnology and Energy, Department of Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"},{"name":"ALiCE\u2014Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1564-6010","authenticated-orcid":false,"given":"Berta N.","family":"Estevinho","sequence":"additional","affiliation":[{"name":"LEPABE\u2014Laboratory for Process Engineering, Environment, Biotechnology and Energy, Department of Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"},{"name":"ALiCE\u2014Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.0954-6820.1957.tb00124.x","article-title":"Acute Promyelocytc Leukemia","volume":"159","author":"Hillestad","year":"2009","journal-title":"Acta Med. Scand."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Zhou, G.-B., Zhao, W.-L., Wang, Z.-Y., Chen, S.-J., and Chen, Z. (2005). Retinoic Acid and Arsenic for Treating Acute Promyelocytic Leukemia. PLoS Med., 2.","DOI":"10.1371\/journal.pmed.0020012"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1182\/blood-2007-07-102798","article-title":"Acute Promyelocytic Leukemia: From Highly Fatal to Highly Curable","volume":"111","author":"Wang","year":"2008","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/bjh.13890","article-title":"Current Standard Treatment of Adult Acute Promyelocytic Leukaemia","volume":"172","author":"Cicconi","year":"2016","journal-title":"Br. J. Haematol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1007\/s00277-022-04954-0","article-title":"Treatment for Relapsed Acute Promyelocytic Leukemia","volume":"101","author":"Yanada","year":"2022","journal-title":"Ann. Hematol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.21037\/sci.2019.10.03","article-title":"Incidence of Acute Promyelocytic Leukemia across Europe: Results of RARECAREnet\u2014A Population-Based Study","volume":"6","author":"Dinmohamed","year":"2019","journal-title":"Stem Cell Investig."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/14656566.2021.1961744","article-title":"Drug Treatment Options for Acute Promyelocytic Leukemia","volume":"23","author":"Ferrara","year":"2022","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/cncr.33933","article-title":"The Cure of Leukemia through the Optimist\u2019s Prism","volume":"128","author":"Kantarjian","year":"2022","journal-title":"Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1200\/JOP.18.00328","article-title":"Treatment of Acute Promyelocytic Leukemia in Adults","volume":"14","author":"Osman","year":"2018","journal-title":"J. Oncol. Pract."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"T69","DOI":"10.1530\/JME-22-0141","article-title":"How Retinoic Acid and Arsenic Transformed Acute Promyelocytic Leukemia Therapy","volume":"69","author":"Korsos","year":"2022","journal-title":"J. Mol. Endocrinol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"101522","DOI":"10.1016\/j.tranon.2022.101522","article-title":"Evolving of Treatment Paradigms and Challenges in Acute Promyelocytic Leukaemia: A Real-World Analysis of 1105 Patients over the Last Three Decades","volume":"25","author":"Diyaer","year":"2022","journal-title":"Transl. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Brown, G., and Marcinkowska, E. (2017). Acute Myeloid Leukaemia: New Targets and Therapies. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18122577"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1158\/1541-7786.MCR-10-0545","article-title":"Curcumin Sensitizes Acute Promyelocytic Leukemia Cells to Unfolded Protein Response-Induced Apoptosis by Blocking the Loss of Misfolded N-CoR Protein","volume":"9","author":"Ng","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1084\/jem.20131121","article-title":"Synergy against PML-RARa: Targeting Transcription, Proteolysis, Differentiation, and Self-Renewal in Acute Promyelocytic Leukemia","volume":"210","author":"Kats","year":"2013","journal-title":"J. Exp. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1521-6926(03)00062-8","article-title":"Molecular Pathogenesis of Acute Promyelocytic Leukaemia and APL Variants","volume":"16","author":"Sirulnik","year":"2003","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(77)91415-5","article-title":"15\/17 TRANSLOCATION, A CONSISTENT CHROMOSOMAL CHANGE IN ACUTE PROMYELOCYTIC LEUKAEMIA","volume":"309","author":"Rowley","year":"1977","journal-title":"Lancet"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/ejh.13872","article-title":"Auer Rods and Faggot Cells: A Review of the History, Significance and Mimics of Two Morphological Curiosities of Enduring Relevance","volume":"110","author":"Sehgal","year":"2023","journal-title":"Eur. J. Haematol."},{"key":"ref_18","unstructured":"Cingam, S.R., and Koshy, N.V. (2022). Acute Promyelocytic Leukemia, StatPearls Publishing."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2147\/OTT.S100513","article-title":"Retinoic Acid and Arsenic Trioxide in the Treatment of Acute Promyelocytic Leukemia: Current Perspectives","volume":"10","author":"McCulloch","year":"2017","journal-title":"Onco. Targets. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2374289519875647","DOI":"10.1177\/2374289519875647","article-title":"Educational Case: Acute Promyelocytic Leukemia With PML-RARA","volume":"6","author":"Kunak","year":"2019","journal-title":"Acad. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.4081\/cp.2011.e11","article-title":"Acute Promyelocytic Leukemia, Hypogranular Variant: A Rare Presentation","volume":"1","author":"Akhtar","year":"2011","journal-title":"Clin. Pract."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/joah.joah_42_21","article-title":"Atypical Morphology and Aberrant Immunophenotypic Expression: A Diagnostic Dilemma in Acute Promyelocytic Leukemia","volume":"13","author":"Verma","year":"2022","journal-title":"J. Appl. Hematol."},{"key":"ref_23","first-page":"405","article-title":"The Flow Cytometric Pattern of CD34, CD15 and CD13 Expression in Acute Myeloblastic Leukemia Is Highly Characteristic of the Presence of PML-RARalpha Gene Rearrangements","volume":"84","author":"Orfao","year":"1999","journal-title":"Haematologica"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/cyto.b.22085","article-title":"Acute Promyelocytic Leukemia: Immunophenotype and Differential Diagnosis by Flow Cytometry","volume":"102","author":"Fang","year":"2022","journal-title":"Cytom. Part B Clin. Cytom."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/annonc\/mdw171","article-title":"Current Management of Newly Diagnosed Acute Promyelocytic Leukemia","volume":"27","author":"Cicconi","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1590\/S1516-84842009005000088","article-title":"Caracter\u00edsticas Gen\u00e9ticas Da Leucemia Promieloc\u00edtica Aguda de Novo TT\u2014Genetics Characteristics of de Novo Acute Promyelocytic Leukemia","volume":"31","author":"Leal","year":"2009","journal-title":"Rev. Bras. Hematol. Hemoter."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2022.871590","article-title":"Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis","volume":"12","author":"Guarnera","year":"2022","journal-title":"Front. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2991\/chi.k.210703.001","article-title":"History of Acute Promyelocytic Leukemia","volume":"3","author":"Sanz","year":"2021","journal-title":"Clin. Hematol. Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood.V41.4.489.489","article-title":"Acute Promyelocytic Leukemia: Results of Treatment by Daunorubicin","volume":"41","author":"Bernard","year":"1973","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood.V86.5.1717.bloodjournal8651717","article-title":"Effect of Aggressive Daunomycin Therapy on Survival in Acute Promyelocytic Leukemia","volume":"86","author":"Head","year":"1995","journal-title":"Blood"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2020.586004","article-title":"Therapeutic Approaches for Acute Promyelocytic Leukaemia: Moving Towards an Orally Chemotherapy-Free Era","volume":"10","author":"Xu","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1182\/blood.V57.6.1000.1000","article-title":"Terminal Differentiation of Human Promyelocytic Leukemic Cells in Primary Culture in Response to Retinoic Acid","volume":"57","author":"Breitman","year":"1981","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1073\/pnas.77.5.2936","article-title":"Induction of Differentiation of the Human Promyelocytic Leukemia Cell Line (HL-60) by Retinoic Acid","volume":"77","author":"Breitman","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V72.2.567.567","article-title":"Use of All-Trans Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia","volume":"72","author":"Huang","year":"1988","journal-title":"Blood"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"992","DOI":"10.18632\/oncotarget.27513","article-title":"Acute Promyelocytic Leukemia (APL): A Review of the Literature","volume":"11","author":"Jimenez","year":"2020","journal-title":"Oncotarget"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1182\/blood-2010-01-266007","article-title":"Risk-Adapted Treatment of Acute Promyelocytic Leukemia Based on All-Trans Retinoic Acid and Anthracycline with Addition of Cytarabine in Consolidation Therapy for High-Risk Patients: Further Improvements in Treatment Outcome","volume":"115","author":"Sanz","year":"2010","journal-title":"Blood"},{"key":"ref_37","first-page":"3015","article-title":"A Modified AIDA Protocol with Anthracycline-Based Consolidation Results in High Antileukemic Efficacy and Reduced Toxicity in Newly Diagnosed PML\/RARalpha-Positive Acute Promyelocytic Leukemia. PETHEMA Group","volume":"94","author":"Sanz","year":"1999","journal-title":"Blood"},{"key":"ref_38","first-page":"1014","article-title":"Molecular Remission in PML\/RAR Alpha-Positive Acute Promyelocytic Leukemia by Combined All-Trans Retinoic Acid and Idarubicin (AIDA) Therapy. Gruppo Italiano-Malattie Ematologiche Maligne Dell\u2019Adulto and Associazione Italiana Di Ematologia Ed Oncologia Pe","volume":"90","author":"Mandelli","year":"1997","journal-title":"Blood"},{"key":"ref_39","first-page":"1247","article-title":"Definition of Relapse Risk and Role of Nonanthracycline Drags for Consolidation in Patients with Acute Promyelocytic Leukemia: A Joint Study of the PETHEMA and GIMEMA Cooperative Groups","volume":"96","author":"Sanz","year":"2000","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1182\/blood-2010-03-276196","article-title":"Front-Line Treatment of Acute Promyelocytic Leukemia with AIDA Induction Followed by Risk-Adapted Consolidation for Adults Younger than 61 Years: Results of the AIDA-2000 Trial of the GIMEMA Group","volume":"116","author":"Avvisati","year":"2010","journal-title":"Blood"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1073\/pnas.0400053101","article-title":"All-Trans Retinoic Acid\/AS2O3 Combination Yields a High Quality Remission and Survival in Newly Diagnosed Acute Promyelocytic Leukemia","volume":"101","author":"Shen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1182\/blood-2010-02-269621","article-title":"Arsenic Trioxide Improves Event-Free and Overall Survival for Adults with Acute Promyelocytic Leukemia: North American Leukemia Intergroup Study C9710","volume":"116","author":"Powell","year":"2010","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e357","DOI":"10.1016\/S2352-3026(15)00115-5","article-title":"Use of Arsenic Trioxide in Remission Induction and Consolidation Therapy for Acute Promyelocytic Leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 Study: A Non-Randomised Phase 2 Trial","volume":"2","author":"Iland","year":"2015","journal-title":"Lancet Haematol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1200\/JCO.2010.28.5031","article-title":"Single-Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Long-Term Follow-up Data","volume":"28","author":"Mathews","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1200\/JCO.2010.32.2107","article-title":"Phase II Study of Single-Agent Arsenic Trioxide for the Front-Line Therapy of Acute Promyelocytic Leukemia","volume":"29","author":"Ghavamzadeh","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1200\/JCO.2008.18.6130","article-title":"Effective Treatment of Acute Promyelocytic Leukemia with All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin","volume":"27","author":"Ravandi","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1300874","article-title":"Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia","volume":"369","author":"Avvisati","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1200\/JCO.2016.67.1982","article-title":"Improved Outcomes with Retinoic Acid and Arsenic Trioxide Compared with Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial","volume":"35","author":"Platzbecker","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1182\/blood-2019-01-894980","article-title":"Management of Acute Promyelocytic Leukemia: Updated Recommendations from an Expert Panel of the European LeukemiaNet","volume":"133","author":"Sanz","year":"2019","journal-title":"Blood"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1098\/rstb.2007.2026","article-title":"Treatment of Acute Promyelocytic Leukaemia with All-Trans Retinoic Acid and Arsenic Trioxide: A Paradigm of Synergistic Molecular Targeting Therapy","volume":"362","author":"Zhou","year":"2007","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1056\/NEJM199307153290307","article-title":"Acute Promyelocytic Leukemia","volume":"329","author":"Warrell","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood.V99.7.2562","article-title":"Acquisition of Potential N-Glycosylation Sites in the Immunoglobulin Variable Region by Somatic Mutation Is a Distinctive Feature of Follicular Lymphoma","volume":"99","author":"Zhu","year":"2002","journal-title":"Blood"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.det.2015.05.007","article-title":"The Role of Systemic Retinoids in the Treatment of Cutaneous T-Cell Lymphoma","volume":"33","author":"Huen","year":"2015","journal-title":"Dermatol. Clin."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40246-019-0248-9","article-title":"Genetics and Functions of the Retinoic Acid Pathway, with Special Emphasis on the Eye","volume":"13","author":"Thompson","year":"2019","journal-title":"Hum. Genomics"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Abdelaal, M.R., Soror, S.H., Elnagar, M.R., and Haffez, H. (2021). Revealing the Potential Application of EC-Synthetic Retinoid Analogues in Anticancer Therapy. Molecules, 26.","DOI":"10.3390\/molecules26020506"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1389200033336900","article-title":"Retinoic Acid Metabolism and Mechanism of Action: A Review","volume":"4","author":"Marill","year":"2003","journal-title":"Curr. Drug Metab."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Hunsu, V.O., Facey, C.O.B., Fields, J.Z., and Boman, B.M. (2021). Retinoids as Chemo-preventive and Molecular-targeted Anti-cancer Therapies. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147731"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.bcp.2004.05.041","article-title":"Epigenetic Gene Silencing in Acute Promyelocytic Leukemia","volume":"68","author":"Villa","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1084\/jem.20050616","article-title":"In Vivo Analysis of the Role of Aberrant Histone Deacetylase Recruitment and RAR\u03b1 Blockade in the Pathogenesis of Acute Promyelocytic Leukemia","volume":"203","author":"Matsushita","year":"2006","journal-title":"J. Exp. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1182\/asheducation-2006.1.156","article-title":"The Biology of Acute Promyelocytic Leukemia and Its Impact on Diagnosis and Treatment","volume":"2006","author":"Ammatuna","year":"2006","journal-title":"Hematology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ccr.2007.05.005","article-title":"Chromatin Modulation by Oncogenic Transcription Factors: New Complexity, New Therapeutic Targets","volume":"11","author":"Hormaeche","year":"2007","journal-title":"Cancer Cell"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Noguera, N., Catalano, G., Banella, C., Divona, M., Faraoni, I., Ottone, T., Arcese, W., and Voso, M. (2019). Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies. Cancers, 11.","DOI":"10.20944\/preprints201910.0159.v1"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"116075","DOI":"10.1016\/j.carbpol.2020.116075","article-title":"Chitosan Nanoparticles Loaded with Clove Essential Oil: Characterization, Antioxidant and Antibacterial Activities","volume":"236","author":"Hadidi","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"125628","DOI":"10.1016\/j.foodchem.2019.125628","article-title":"Ginger Essential Oil-Based Microencapsulation as an Efficient Delivery System for the Improvement of Jujube (Ziziphus Jujuba Mill.) Fruit Quality","volume":"306","author":"Ban","year":"2020","journal-title":"Food Chem."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Vinner, G., Rezaie-Yazdi, Z., Leppanen, M., Stapley, A., Leaper, M., and Malik, D. (2019). Microencapsulation of Salmonella-Specific Bacteriophage Felix O1 Using Spray-Drying in a PH-Responsive Formulation and Direct Compression Tableting of Powders into a Solid Oral Dosage Form. Pharmaceuticals, 12.","DOI":"10.3390\/ph12010043"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1021\/acs.molpharmaceut.7b00529","article-title":"In Vitro Dissolution, Cellular Membrane Permeability, and Anti-Inflammatory Response of Resveratrol-Encapsulated Mesoporous Silica Nanoparticles","volume":"14","author":"Florek","year":"2017","journal-title":"Mol. Pharm."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.tifs.2021.12.026","article-title":"Microencapsulation by Spray Chilling in the Food Industry: Opportunities, Challenges, and Innovations","volume":"120","author":"Oliveira","year":"2022","journal-title":"Trends Food Sci. Technol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cofs.2019.11.006","article-title":"Bioactive-Loaded Nanocarriers for Functional Foods: From Designing to Bioavailability","volume":"33","author":"Dima","year":"2020","journal-title":"Curr. Opin. Food Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cis.2018.02.002","article-title":"Encapsulation, Protection, and Delivery of Bioactive Proteins and Peptides Using Nanoparticle and Microparticle Systems: A Review","volume":"253","author":"McClements","year":"2018","journal-title":"Adv. Colloid Interface Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"100832","DOI":"10.1016\/j.cofs.2022.100832","article-title":"Enhancing the Bioavailability of Encapsulated Hydrophobic Nutraceuticals: Insights from in Vitro, in Vivo, and Clinical Studies","volume":"45","author":"Livney","year":"2022","journal-title":"Curr. Opin. Food Sci."},{"key":"ref_71","unstructured":"Shield, J., Kuler, J., and Gurnani, A. (2017). Developing New Functional Food and Nutraceutical Products, Elsevier."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cis.2010.06.010","article-title":"Structured Emulsion-Based Delivery Systems: Controlling the Digestion and Release of Lipophilic Food Components","volume":"159","author":"McClements","year":"2010","journal-title":"Adv. Colloid Interface Sci."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tifs.2020.07.004","article-title":"Micro and Nano-Encapsulation of Vegetable and Essential Oils to Develop Functional Food Products with Improved Nutritional Profiles","volume":"104","author":"Delshadi","year":"2020","journal-title":"Trends Food Sci. Technol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408398.2014.971353","article-title":"A Comprehensive Overview on the Micro- and Nano-Technological Encapsulation Advances for Enhancing the Chemical Stability and Bioavailability of Carotenoids","volume":"58","author":"Soukoulis","year":"2018","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Montan\u00e9, X., Bajek, A., Roszkowski, K., Montorn\u00e9s, J.M., Giamberini, M., Roszkowski, S., Kowalczyk, O., Garcia-Valls, R., and Tylkowski, B. (2020). Encapsulation for Cancer Therapy. Molecules, 25.","DOI":"10.3390\/molecules25071605"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tifs.2021.05.022","article-title":"Encapsulation of Probiotics and Nutraceuticals: Applications in Functional Food Industry","volume":"114","author":"Reque","year":"2021","journal-title":"Trends Food Sci. Technol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.colsurfa.2017.10.076","article-title":"Production, Properties, and Applications of Solid Self-Emulsifying Delivery Systems (S-SEDS) in the Food and Pharmaceutical Industries","volume":"538","author":"Nikmaram","year":"2018","journal-title":"Colloids Surfaces A Physicochem. Eng. Asp."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.tifs.2021.06.007","article-title":"Methodologies for Simulation of Gastrointestinal Digestion of Different Controlled Delivery Systems and Further Uptake of Encapsulated Bioactive Compounds","volume":"114","author":"Estevinho","year":"2021","journal-title":"Trends Food Sci. Technol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/10408399309527645","article-title":"Encapsulation of Food Ingredients","volume":"33","author":"Shahidi","year":"1993","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-food-032818-121641","article-title":"Advances in Spray-Drying Encapsulation of Food Bioactive Ingredients: From Microcapsules to Nanocapsules","volume":"10","author":"Assadpour","year":"2019","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.powtec.2017.08.008","article-title":"Process Analysis and Global Optimization for the Microencapsulation of Phytosterols by Spray Drying","volume":"321","author":"Constenla","year":"2017","journal-title":"Powder Technol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.tifs.2017.05.006","article-title":"Trends of Spray Drying: A Critical Review on Drying of Fruit and Vegetable Juices","volume":"65","author":"Shishir","year":"2017","journal-title":"Trends Food Sci. Technol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ijpharm.2018.05.037","article-title":"Nano Spray Drying for Encapsulation of Pharmaceuticals","volume":"546","author":"Arpagaus","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejpb.2019.08.014","article-title":"Formulation Approaches for Improved Retinoids Delivery in the Treatment of Several Pathologies","volume":"143","author":"Estevinho","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Bahlool, A.Z., Fattah, S., O\u2019Sullivan, A., Cavanagh, B., MacLoughlin, R., Keane, J., O\u2019Sullivan, M.P., and Cryan, S.-A. (2022). Development of Inhalable ATRA-Loaded PLGA Nanoparticles as Host-Directed Immunotherapy against Tuberculosis. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14081745"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"122162","DOI":"10.1016\/j.ijpharm.2022.122162","article-title":"Laser-Assisted Nanoparticle Delivery to Promote Skin Absorption and Penetration Depth of Retinoic Acid with the Aim for Treating Photoaging","volume":"627","author":"Lee","year":"2022","journal-title":"Int. J. Pharm."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"125671","DOI":"10.1016\/j.colsurfa.2020.125671","article-title":"Retinoic Acid Core-Shell Lipoplexes for the Treatment of Colorectal Cancer","volume":"609","author":"Ture","year":"2021","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-18042-2","article-title":"Advances and Challenges in Retinoid Delivery Systems in Regenerative and Therapeutic Medicine","volume":"11","author":"Ferreira","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Giuli, M.V., Hanieh, P.N., Giuliani, E., Rinaldi, F., Marianecci, C., Screpanti, I., Checquolo, S., and Carafa, M. (2020). Current Trends in ATRA Delivery for Cancer Therapy. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12080707"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3835(98)00226-2","article-title":"Altered Metabolism of All-Trans-Retinoic Acid in Liposome-Encapsulated Form","volume":"134","author":"Parthasarathy","year":"1998","journal-title":"Cancer Lett."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1080\/10428190500174737","article-title":"Regulation of a Highly Specific Retinoic Acid-4-Hydroxylase (CYP26A1) Enzyme and All- Trans -Retinoic Acid Metabolism in Human Intestinal, Liver, Endothelial, and Acute Promyelocytic Leukemia Cells","volume":"46","author":"Ozpolat","year":"2005","journal-title":"Leuk. Lymphoma"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ejps.2011.10.014","article-title":"All-Trans Retinoic Acid Loaded Block Copolymer Nanoparticles Efficiently Induce Cellular Differentiation in HL-60 Cells","volume":"44","author":"Tiwari","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1166\/jnn.2016.11677","article-title":"Improved In Vitro Antileukemic Activity of All-Trans Retinoic Acid Loaded in Cholesteryl Butyrate Solid Lipid Nanoparticles","volume":"16","author":"Silva","year":"2016","journal-title":"J. Nanosci. Nanotechnol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jconrel.2004.12.016","article-title":"Modified Polyvinylalcohol for Encapsulation of All-Trans-Retinoic Acid in Polymeric Micelles","volume":"103","author":"Zuccari","year":"2005","journal-title":"J. Control. Release"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.powtec.2019.01.062","article-title":"Characterization of Biopolymer-Based Systems Obtained by Spray-Drying for Retinoic Acid Controlled Delivery","volume":"345","author":"Estevinho","year":"2019","journal-title":"Powder Technol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"107193","DOI":"10.1016\/j.foodhyd.2021.107193","article-title":"Spray-Drying of Oil-in-Water Emulsions for Encapsulation of Retinoic Acid: Polysaccharide- and Protein-Based Microparticles Characterization and Controlled Release Studies","volume":"124","author":"Estevinho","year":"2022","journal-title":"Food Hydrocoll."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"107310","DOI":"10.1016\/j.foodhyd.2021.107310","article-title":"Microencapsulation of Retinoic Acid by Atomization into Biopolymeric Matrices: Binary and Ternary Blends of Alginic Acid Sodium, Xanthan Gum and Modified Chitosan","volume":"124","author":"Estevinho","year":"2022","journal-title":"Food Hydrocoll."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves, A., Rocha, F., and Estevinho, B.N. (2022). Application of Ethyl Cellulose and Ethyl Cellulose + Polyethylene Glycol for the Development of Polymer-Based Formulations Using Spray-Drying Technology for Retinoic Acid Encapsulation. Foods, 11.","DOI":"10.3390\/foods11162533"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.ijbiomac.2022.10.207","article-title":"Co-Encapsulation of Retinoic Acid, Curcumin and Resveratrol by Spray-Drying of Alginic Acid Sodium-Based Emulsions and Ethyl Cellulose-Based Solutions: Impact on the Co-Delivery Profiles","volume":"224","author":"Rocha","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_100","first-page":"4361","article-title":"Curcumin-Induced Cell Cycle Arrest and Apoptosis in Human Acute Promyelocytic Leukemia HL-60 Cells via MMP Changes and Caspase-3 Activation","volume":"26","author":"Tan","year":"2006","journal-title":"Anticancer Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/cmdc.201200293","article-title":"Curcumin Analogues with Potent and Selective Anti-Proliferative Activity on Acute Promyelocytic Leukemia: Involvement of Accumulated Misfolded Nuclear Receptor Co-Repressor (N-CoR) Protein as a Basis for Selective Activity","volume":"7","author":"Tan","year":"2012","journal-title":"ChemMedChem"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1182\/blood.V106.11.4456.4456","article-title":"Curcumin Enhances Differentiation of All-Trans Retinoic Acid (ATRA)-Sensitive and ATRA-Resistant Acute Promyelocytic (APL) Cells","volume":"106","author":"Kini","year":"2005","journal-title":"Blood"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.powtec.2019.07.079","article-title":"Potential Food Application of Resveratrol Microparticles: Characterization and Controlled Release Studies","volume":"355","author":"Cardoso","year":"2019","journal-title":"Powder Technol."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Czop, M., Bogucka-Kocka, A., Kubrak, T., Knap-Czop, K., Makuch-Kocka, A., Galkowski, D., Wawer, J., Kocki, T., and Kocki, J. (2019). Imaging Flow Cytometric Analysis of Stilbene-Dependent Apoptosis in Drug Resistant Human Leukemic Cell Lines. Molecules, 24.","DOI":"10.3390\/molecules24101896"},{"key":"ref_105","first-page":"4285","article-title":"Preliminary Results Indicate Resveratrol Affects Proliferation and Apoptosis of Leukemia Cells by Regulating PTEN\/PI3K\/AKT Pathway","volume":"23","author":"Meng","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/16\/2\/180\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:14:57Z","timestamp":1760120097000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/16\/2\/180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,24]]},"references-count":105,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ph16020180"],"URL":"https:\/\/doi.org\/10.3390\/ph16020180","relation":{},"ISSN":["1424-8247"],"issn-type":[{"type":"electronic","value":"1424-8247"}],"subject":[],"published":{"date-parts":[[2023,1,24]]}}}